Skip to content

Ton Shen Health Recalls “DHZC-2 Tablet” Because of Possible Health Risk

This is a reprint of an FDA Alert.

For Immediate Release
August 11, 2016

Contact

Consumers

Ton Shen Health
1-312-842-2775

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the company.

Ton Shen Health of Chicago, IL, is recalling its “DHZC-2” Tablets because they have the potential to be contaminated with elevated levels of lead, a naturally occurring element which can affect multiple body system and particularly harmful to young children. Lead poisoning can happen if a person is exposed to high levels of lead over short period of time.
The recalled “DHZC-2” tablets were mostly sold locally in Chicago area in retails stores and some were distributed to other states through mail orders.

The product comes in a 1.6 ounce, white plastic package marked with lot # 2163-844 on the bottom. UPC: 616042102727

One illness has been reported to date in connection with this problem.

The potential for contamination was noted after FDA notice of higher level of lead presence in DHZC-2 samples.

The sale of the product has been suspended and inventory put on hold while FDA and the company continue to investigate the source of the problem.

Consumers who have purchased DHZC-2 tablets are urged to return them to the place of purchase for a full refund. Consumers with questions may contact the company at 1-312-842-2775 central standard time, Monday to Friday, from 9:30AM to 5:00PM.

DHZC-2

Scroll To Top